{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-051379","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.532774+00:00","generated_at":"2026-05-16T02:42:54.335352+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"confidence":"high","headline":"Plus Therapeutics Approves FY2025 Cash Bonuses: CEO Hedrick Gets $305,663, CFO Sims Gets $149,175","bullets":["On Feb 9, 2026, Compensation Committee approved discretionary cash bonuses for Named Executive Officers for FY2025.","CEO Marc H. Hedrick received a $305,663 cash bonus; total 2025 compensation was $5,566,732.","CFO Andrew Sims received a $149,175 cash bonus; total 2025 compensation was $1,631,279.","Former CMO Norman LaFrance, who stepped down in June 2024, received $0 compensation in FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-051379","json":"https://secwatch.observer/filing/0001193125-26-051379.json","markdown":"https://secwatch.observer/filing/0001193125-26-051379.md","text":"https://secwatch.observer/filing/0001193125-26-051379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/0001193125-26-051379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/pstv-20260209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T02:42:54.335352+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}